A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors
Tolcher, A.W., Papadopoulos, K.P., Patnaik, A., Wilson, K., Thayer, S., Zanghi, J., Gemo, A.T., Kavanaugh, W.M., Keer, H.N., LoRusso, P.M.
Published in Annals of oncology (01.03.2016)
Published in Annals of oncology (01.03.2016)
Get full text
Journal Article
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, Mary-Ellen, Bubley, Glenn J, Shuster, Todd D, Frantz, Martha E, Spooner, Amy E, Ogata, George K, Keer, Harold N, Balk, Steven P
Published in The New England journal of medicine (25.05.1995)
Published in The New England journal of medicine (25.05.1995)
Get full text
Journal Article
S217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T‐CELL LYMPHOMA AND 51 CUTANEOUS T‐CELL LYMPHOMA SUBJECTS WITH RELAPSED REFRACTORY DISEASE
Michot, J.‐M., Mehta, A., Samaniego, F., Bachy, E., Zinzani, P. L., Prica, A., Colins, G. P., Ribrag, V, Wagner‐Johnston, N., El‐Sharkawi, D., O'Connor, O. A., Wilcox, R., Wang, L., Wilson, L., Sims, M., Taylor, J. A., Keer, H. N., Foss, F.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo
Keer, H N, Kozlowski, J M, Tsai, Y C, Lee, C, McEwan, R N, Grayhack, J T
Published in The Journal of urology (01.02.1990)
Published in The Journal of urology (01.02.1990)
Get more information
Journal Article
DNA profile of nephrogenic adenoma assessed by flow cytometry
Gaylis, Franklin D., Keer, Harold N., Bauer, Kenneth D., Kozlowski, James M., Grayhack, John T.
Published in Urology (Ridgewood, N.J.) (01.02.1993)
Published in Urology (Ridgewood, N.J.) (01.02.1993)
Get full text
Journal Article
Components of the plasminogen-plasmin system in human tumor cell lines
Kwaan, H C, Keer, H N, Radosevich, J A, Cajot, J F, Ernst, R
Published in Seminars in thrombosis and hemostasis (01.07.1991)
Published in Seminars in thrombosis and hemostasis (01.07.1991)
Get more information
Journal Article
Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior
Keer, H N, Gaylis, F D, Kozlowski, J M, Kwaan, H C, Bauer, K D, Sinha, A A, Wilson, M J
Published in The Prostate (1991)
Published in The Prostate (1991)
Get more information
Journal Article
A phase II study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC)
Srinivasan, R., Choueiri, T. K., Vaishampayan, U., Rosenberg, J. E., Stein, M. N., Logan, T., Bukowski, R. M., Mueller, T., Keer, H. N., Linehan, W. M.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study
Jhawer, M. P., Kindler, H. L., Wainberg, Z. A., Hecht, J. R., Kerr, R. O., Ford, J. M., Henderson, C., Mueller, T., Keer, H. N., Shah, M. A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article